RO 700004

Drug Profile

RO 700004

Alternative Names: RS 100975

Latest Information Update: 25 Nov 2005

Price : $50

At a glance

  • Originator Roche Palo Alto LLC
  • Class Small molecules
  • Mechanism of Action Alpha 1 adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Benign prostatic hyperplasia; Erectile dysfunction

Most Recent Events

  • 25 Nov 2005 No development reported - Clinical-Phase-Unknown for Erectile dysfunction in USA (PO)
  • 25 Nov 2005 No development reported - Phase-II for Benign prostatic hyperplasia in USA (unspecified route)
  • 29 Aug 2002 A study has been added to the adverse events and Mens Health therapeutic trials sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top